SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 258 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $203,273 | -98.2% | 1,775 | -98.8% | 0.01% | -99.2% |
| Q3 2019 | $11,219,000 | +183.0% | 148,947 | +396.5% | 0.84% | +310.7% |
| Q2 2018 | $3,965,000 | +22.3% | 30,000 | -31.5% | 0.20% | +48.6% |
| Q1 2018 | $3,243,000 | -12.9% | 43,767 | -34.6% | 0.14% | -29.2% |
| Q4 2017 | $3,722,000 | -45.3% | 66,891 | -55.4% | 0.20% | -43.1% |
| Q3 2017 | $6,805,000 | +134.4% | 150,023 | +74.2% | 0.34% | +118.5% |
| Q2 2017 | $2,903,000 | -13.6% | 86,100 | -24.1% | 0.16% | -5.4% |
| Q1 2017 | $3,360,000 | -60.2% | 113,500 | -63.1% | 0.17% | -70.3% |
| Q4 2016 | $8,432,000 | +3034.6% | 307,400 | +6926.3% | 0.56% | +3620.0% |
| Q3 2016 | $269,000 | -95.8% | 4,375 | -98.7% | 0.02% | -95.5% |
| Q2 2016 | $6,459,000 | +41.9% | 338,675 | +138.8% | 0.34% | -13.6% |
| Q3 2015 | $4,553,000 | +92.8% | 141,813 | +183.6% | 0.39% | +76.5% |
| Q3 2013 | $2,361,000 | -19.9% | 50,000 | -35.5% | 0.22% | -26.6% |
| Q2 2013 | $2,948,000 | – | 77,500 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |